clopidogrel 23andMe Begins Reporting PGx Variants With Drug Info Under Recent FDA Clearance Premium The new reports link variants in CYP2C19 to the safety and efficacy of two drugs, a commonly prescribed antiplatelet drug and an antidepressant. Meta-Analysis Supports Pharmacogenomic Testing Prior to Anti-Platelet Therapy The study showed that CYP2C19 genotyping could help clinicians reduce ischemic events in patients with coronary artery disease by tailoring their treatment. FDA Joins PGx Collaborative Community but Effect on Field is Unclear Premium The community is poised to be the primary channel for stakeholders to communicate PGx concerns with FDA, but it is unclear if all stakeholders will participate. Trial Shows Some Benefit of Genetically Guided Antiplatelet Therapy After Balloon Angioplasty The TAILOR-PCI trial did not meet its primary endpoint but did find that genetic testing led to a reduction in adverse events, though not as much as expected. 23andMe Garners FDA Clearance for CYP2C19 PGx Test Report The firm can now tell customers if their genotypes may impact their response to clopidogrel and citalopram without the need for confirmatory testing. Jan 28, 2020 Spartan Bioscience Pushing to Commercialize Personalized Heart Test Premium Jul 8, 2015 New Analysis Examines Financial Impact of Genotyping Patients to Guide Anti-Platelet Therapy Premium Nov 5, 2014 After Health Canada Approval, Spartan Plans to Launch Point-of-Care CYP2C19 Dx via Pharmacy Pilots Premium Apr 16, 2014 Lawsuit in Hawaii against Plavix Sponsors Alleges Burden is on Pharma to Market PGx Information Premium Nov 20, 2013 In Prescribing Study, Few Doctors Altered Treatment for Poor Plavix Metabolizers Based on Genotype Premium Oct 23, 2013 Transgenomic Enlists PDI to Market Cardiac PGx Test; PDI Entering MDx Space Premium Sep 12, 2013 Mount Sinai Group Publishes Allele-Specific PCR Assay for Novel CYP2C19 Variants Premium Sep 4, 2013 Spartan to Continue Talks with FDA as it Aims for Point-of-Care Indication for CYP2C19 Test Premium Aug 29, 2013 FDA Clearance of Spartan Assay Inches CYP2C19 Genotyping Closer to Point of Care Premium Aug 21, 2013 After Plavix PGx Experience, UF Rolling Out Similar Genetic Testing Program to Community Settings Premium Mar 13, 2013 Spartan Bioscience Building Evidence for Point-of-Care PGx Testing to Guide Antiplatelet Therapy Premium Nov 14, 2012 FDA Clears Nanosphere's CYP2C19 Test to Guide Therapeutic Strategy, Not Predict Response Premium Jul 25, 2012 MDx/CDx Focus: Cepheid Updates BCR-ABL Test; Medicare Covers Transgenomic Plavix Dx; Lungevity Awards Premium Jun 28, 2012 U of Florida PGx Program Adopts Life Tech OpenArray Assays to Screen Catheterization Patients Premium Jun 27, 2012 UF to Genotype All Comers at Cath Lab to Personalize Treatment with Plavix, Eventually Other Drugs Premium May 9, 2012 Following Merger, Express Scripts May Cut Back Medco's Personalized Medicine Programs Premium Apr 4, 2012 Study: Higher Plavix Dose Doesn't Improve Response for CYP2C19*2 Carriers; Effient May Be Best Option Premium Apr 4, 2012 PGx Highlights from American College of Cardiology Annual Meeting Premium Mar 21, 2012 Exome Sequencing IDs Plavix Response Variants that Could Lead to Better PGx Test Premium Feb 15, 2012 Dx Developers' Sales Pitch to Pharma Could be Key Factor in Marketing Some Tests Premium Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.